Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)
| קרן | National Cancer Institute/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 27/09/2019 |
| פקולטה | Engineering, Exact Sciences, Life Sciences, Medicine |
| תיאור | This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research.
Funding: $300,000 per year Duration: 3 years
Research Authority due date: 10 days prior to submission LOI (encouraged) due dates: 7.2.19, 28.4.19, 27.8.19 Full proposal due dates: 7.3.19, 28.5.19. 27.9.19
|
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 08/01/2019 |
